Jill Fiedler‐Kelly

Nonclinical and Pharmacokinetic Assessments To Evaluate the Potential of Tedizolid and Linezolid To Affect Mitochondrial Function

Shawn D. Flanagan, Edward E. McKee, Debaditya Das et al. · Antimicrobial Agents and Chemotherapy · 2014 · 92 citations · Full text

Affect Mitochondrial Function, Cardiovascular Pharmacology, Pharmacotherapy +24

Tedizolid Population Pharmacokinetics, Exposure Response, and Target Attainment

Shawn D. Flanagan, Julie Passarell, Qin Lü et al. · Antimicrobial Agents and Chemotherapy · 2014 · 85 citations · Full text

Pharmaceutical Science, Pharmacotherapy, Dermatology +18

Relationship between drug exposure and the efficacy and safety of bupropion sustained release for smoking cessation

Joseph A. Johnston, Jill Fiedler‐Kelly, Elbert D. Glover et al. · Nicotine & Tobacco Research · 2001 · 83 citations

Tobacco Cessation, Pharmacotherapy, Harm Reduction +19

Pharmacokinetic/Pharmacodynamic Modeling and Simulation of Neutropenia during Phase I Development of Liposome-Entrapped Paclitaxel

Gerald J. Fetterly, Thaddeus H. Grasela, Jeffrey W. Sherman et al. · Clinical Cancer Research · 2008 · 70 citations · Full text

Prospective Use of Population Pharmacokinetics/ Pharmacodynamics in the Development of Cisatracurium

Virginia D. Schmith, Jill Fiedler‐Kelly, Luann Phillips et al. · Pharmaceutical Research · 1997 · 29 citations